The aim of Cancer Genetics is to publish high quality scientific papers on the cellular, genetic and molecular aspects of cancer, including cancer predisposition and clinical diagnostic applications. Specific areas of interest include descriptions of new chromosomal, molecular or epigenetic alterations in benign and malignant diseases; novel laboratory approaches for identification and characterization of chromosomal rearrangements or genomic alterations in cancer cells; correlation of genetic changes with pathology and clinical presentation; and the molecular genetics of cancer predisposition. To reach a basic science and clinical multidisciplinary audience, we welcome original full-length articles, reviews, meeting summaries, brief reports, and letters to the editor. 

Review Articles
Original Research
Meeting summaries
Commentaries
Brief Communications
Letters to the Editor
Case Reports for Cancer Curation

Editor-in-Chief
Shashikant Kulkarni
Shashikant Kulkarni
Baylor College of Medicine, Houston, Texas, USA
Co-Editors
Hussam Al-Kateb
Hussam Al-Kateb
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
Immaculata De Vivo
Immaculata De Vivo
Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA
Marilyn M. Li
Marilyn M. Li
University of Pennsylvania, Philadelphia, Pennsylvania, USA
Raja Luthra
Raja Luthra
The Unversity of Texas MD Anderson Cancer Center, Houston, Texas, USA
Sameek Roychowdhury
Sameek Roychowdhury
The Ohio State University, Columbus, Ohio, USA
Case Reports Editor
Deborah I. Ritter
Deborah I. Ritter
Baylor College of Medicine, Houston, Texas, USA
Editorial Board
Frederic Barr
National Institute of Health (NIH), Bethesda, Maryland, USA
AnneMarie Block
Roswell Park Cancer Institute, Buffalo, New York, USA
Julia Bridge
University of Nebraska Medical Center (UNMC), Omaha, Nebraska, USA
Paola Dal Cin
Brigham and Women's Hospital, Boston, Massachusetts, USA
Linda Cooley
Children's Mercy Hospital, Kansas City, Missouri, USA
Nyla Heerema
Ohio State University Medical Center, Columbus, Ohio, USA
Robert Jenkins
Mayo Clinic, Rochester, Minnesota, USA
Anne Kallioniemi
University of Tampere, Tampere, Finland
Rashmi Kanagal-Shamanna
University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
Jennifer J. Laffin
University of Wisconsin at Madison, Madison, Wisconsin, USA
David Malkin
The Hospital for Sick Children (SickKids), Toronto, Ontario, Canada
Cristina Mecucci
Ematologia E Immunol Clinica, Perugia, Italy
Aurelia Meloni-Ehrig
CSI Laboratories, Alpharetta, Georgia, USA
Frederico Monzon
Invitae Corporation, San Francisco, California, USA
Katherine Nathanson
University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
Suraj Peri
Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
Diane Persons
University of Kansas Medical Center, Kansas City, Kansas, USA
Gordana Raca
Children's Hospital Los Angeles, Los Angeles, California, USA
Thomas Ried
National Institutes of Health (NIH), Bethesda, Maryland, USA
Carla B. Ripamonti
Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
Michael Rossi
Emory University, Atlanta, Georgia, USA
Malini Sathanoori
PathGroup, Nashville, Tennessee, USA
Joshua Schiffman
Huntsman Cancer Institute, Salt Lake City, Utah, USA
Urvashi Surti
Magee-Womens Hospital of UPMC, Pittsburgh, Pennsylvania, USA
Joseph Testa
Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
Nancy Zeleznik-Le
Loyola University Chicago, Maywood, IL, Illinois, USA